LONGBOARD PHARMACEUTIC

Longboard Pharmaceuticals to Participate in the Cantor Neurology & Psychiatry Conference

29 Sep 2022 15:01:00 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals to Participate in Upcoming Investor Conferences

01 Sep 2022 15:01:00 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2022 Financial Results

04 Aug 2022 15:05:01 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference

03 Aug 2022 07:30:00 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals to Present at the JMP Securities 2022 Life Sciences Conference on June 15

07 Jun 2022 07:30:00 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals to Participate in Five Upcoming Epilepsy-Focused Conferences this Summer

01 Jun 2022 07:30:00 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals to Participate in Upcoming Investor Events

12 May 2022 07:30:00 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2022 Financial Results

05 May 2022 15:05:02 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals to Present Phase 1 Data for LP352 at the American Academy of Neurology Annual Meeting

01 Apr 2022 07:30:00 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals to Participate in Cantor Fitzgerald’s Virtual Rare Orphan Disease Summit

23 Mar 2022 15:01:00 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals to Participate in Maxim Group 2022 Virtual Growth Conference

22 Mar 2022 15:01:00 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals Announces the Appointment of Highly Accomplished Healthcare Executive Randall Kaye, M.D., as Chief Medical Officer

21 Mar 2022 15:01:00 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals Provides Corporate Update and Reports Full Year 2021 Financial Results

03 Mar 2022 15:05:01 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference

05 Jan 2022 07:30:00 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals Appoints Life Sciences Executive Dr. Jane Tiller to Board of Directors

17 Nov 2021 07:30:00 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals to Participate in Upcoming Investor Conferences

11 Nov 2021 07:30:00 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial Results

04 Nov 2021 15:05:03 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals Announces Steven W. Spector Joins the Company as General Counsel

02 Nov 2021 07:30:01 By Nasdaq GlobeNewswire

Longboard Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference on September 28, 2021

21 Sep 2021 07:30:00 By Nasdaq GlobeNewswire